Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 3P50CA247749-05S1
MSK SPORE in Genomic Instability in Breast Cancer
National Institutes of Health
Grant: 1R01CA281928-01
Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5U24CA264028-03
The MSK Genomic Data Analysis Center for Tumor Evolution
National Institutes of Health
Grant: 1R01CA269382-01A1
POTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION
National Institutes of Health
Grant: 1K99CA256508-01
Single cell quantification of genomic instability in cancer as a determinant of therapeutic response
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: U24 CA264028
NCI NIH HHS
Grant: P50 CA247749
NCI NIH HHS
Grant: K99 CA256508
NCI NIH HHS
Grant: R01 CA281928
NCI NIH HHS
Grant: R01 CA269382
Fields of Study
Keywords
Sustainable Development Goals